TSLP‐targeting therapy: Beyond allergy?
Prif Awduron: | Risa Ebina‐Shibuya, Warren J. Leonard |
---|---|
Fformat: | Erthygl |
Iaith: | English |
Cyhoeddwyd: |
Wiley
2023-05-01
|
Cyfres: | Clinical and Translational Medicine |
Pynciau: | |
Mynediad Ar-lein: | https://doi.org/10.1002/ctm2.1241 |
Eitemau Tebyg
-
Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?
gan: Andrew Menzies-Gow, et al.
Cyhoeddwyd: (2020-10-01) -
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
gan: Andrew Menzies-Gow, et al.
Cyhoeddwyd: (2020-10-01) -
Role of the TSLP and its Receptor in the Treatment of Asthma
gan: Miguel Estravís, et al.
Cyhoeddwyd: (2023-04-01) -
Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b Study
gan: Corren J, et al.
Cyhoeddwyd: (2021-01-01) -
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with and without Nasal Polyposis: A Post Hoc Analysis of the Phase 2b PATHWAY Study
gan: Emson C, et al.
Cyhoeddwyd: (2021-02-01)